Technology

Adial Pharmaceuticals

$1.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-6.80%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADIL and other stocks, options, and ETFs commission-free!

About ADIL

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA. The listed name for ADIL is Adial Pharmaceuticals, Inc Common Stock.

CEO
William B. Stilley
Employees
4
Headquarters
Charlottesville, Virginia
Founded
2010
Market Cap
27.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
543.45K
High Today
$2.10
Low Today
$1.92
Open Price
$2.07
Volume
328.44K
52 Week High
$4.00
52 Week Low
$1.00

Collections

ADIL Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 19, Pre-Market

You May Also Like

ALUS+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure